StockTipsArenaBeta

BUY Aurobindo Pharma — Motilal Oswal

BUYAurobindo Pharma

byMotilal OswalHorizon: NA (inferred 1 year)5 Aug 2025via Institutional / Brokerage Research

Entry₹1,079.3Inferred
Target₹1,300
Total upside +20.45% (call closed)
Stop lossNot given
Exit₹1,30011 Mar 2026, 12:03 pm
Target hit+20.45%0.00%upside left
Follow Motilal Oswal for new calls(61% target hit, 1112 closed calls)Get alertsWatch AUROPHARMA for new buy/sell callsGet alertsSee 10 active Long-term calls on AUROPHARMA

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Sept, 5:00 am IST
1 supporting0 opposing
Supports the BUY call (1)

5 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·15 Feb · 3w ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.